The global alopecia market size was valued at USD 8.52 billion in 2018 and is expected to expand at a CAGR of 5.5% over the forecast period. Key factors attributed to the revenue growth include rising prevalence of chronic disorders such as hypothyroidism, hyperthyroidism, acute stress disorder, hypopituitarism, and lupus.